1. Home
  2. VRA vs LCTX Comparison

VRA vs LCTX Comparison

Compare VRA & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vera Bradley Inc.

VRA

Vera Bradley Inc.

HOLD

Current Price

$2.53

Market Cap

60.6M

ML Signal

HOLD

Logo Lineage Cell Therapeutics Inc.

LCTX

Lineage Cell Therapeutics Inc.

HOLD

Current Price

$1.65

Market Cap

407.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRA
LCTX
Founded
1982
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
60.6M
407.7M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
VRA
LCTX
Price
$2.53
$1.65
Analyst Decision
Buy
Strong Buy
Analyst Count
3
4
Target Price
$4.00
$4.25
AVG Volume (30 Days)
1.1M
1.2M
Earning Date
12-11-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$324,296,000.00
$10,816,000.00
Revenue This Year
N/A
$6.32
Revenue Next Year
$1.61
$124.49
P/E Ratio
N/A
N/A
Revenue Growth
N/A
24.05
52 Week Low
$1.39
$0.37
52 Week High
$4.01
$2.09

Technical Indicators

Market Signals
Indicator
VRA
LCTX
Relative Strength Index (RSI) 57.05 45.35
Support Level $2.10 $1.58
Resistance Level $2.50 $1.77
Average True Range (ATR) 0.17 0.08
MACD 0.04 -0.01
Stochastic Oscillator 96.79 28.57

Price Performance

Historical Comparison
VRA
LCTX

About VRA Vera Bradley Inc.

Vera Bradley Inc designs women's handbags, travel items, and accessories. Each category comprises a substantial component of total sales, with the bags category comprising the majority of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct, Vera Bradley Indirect, and Pura Vida. The majority of revenue is from the Vera Bradley Direct segment.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.

Share on Social Networks: